CYTOGEN CORPORATION
Cytogen is a biopharmaceutical company that is focused on the development and building of pharmaceutical products for cancer patients. Cytogen markets QUADRAMET, PROSTASCINT, CAPHOSOL, and SOLTAMOX. It also develops CYT-500, a third-generation radiolabeled antibody to treat prostate cancer. Cytogen was acquired by EUSA Pharma in May 2008. Cytogen was founded by Thomas J. McKearn in 1980. It is based in Princeton, New Jersey.
CYTOGEN CORPORATION
Industry:
Biotechnology Medical
Founded:
1980-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.cytogen.com
Total Employee:
101+
Status:
Active
Contact:
(609)750-8200
Technology used in webpage:
SPF Nginx DOSarrest Uniregistry
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Geistlich Pharma
Geistlich Pharma North America brings the leader in regenerative dentistry.
MabVax Therapeutics
MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Official Site Inspections
http://www.cytogen.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
